GGrantIndex
← Leaderboards

Stefanie Sarantopoulos

Univ Of North Carolina Chapel Hill

$7,871,947
Attributed
$7,871,947
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,871,947 · 4

By mechanism

R01$6,866,391 · 1
K08$520,352 · 1
R21$415,257 · 1
P30$69,947 · 1

Top collaborators

No co-investigators on record.

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Hematopoietic Stem Cell Transplantation

Research focus

Hematopoietic Stem Cell TransplantationImmuneB-Lymphocyte SubsetsAntibodiesReceptorResponseChronic Graft Versus Host DiseaseSignal TransductionAllogenicB-LymphocytesCancer PatientProductionResearch PersonnelBone MarrowLifeHematological DiseaseReceptor SignalingAutoimmune DiseasesPathologicMorbidity - Disease RateAmericanBloodPathologyPathway Interactions

Grant awards (16)

Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2025 · HL · contact PI
Harnessing B Cells after Stem Cell Transplant to Produce Novel CAR-Ts$415,257
R21 · FY2025 · CA · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$717,072
R01 · FY2024 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2023 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$731,706
R01 · FY2022 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$736,536
R01 · FY2021 · HL · contact PI
Immuno-Oncology Program$69,947
P30 · FY2021 · CA · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2019 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2018 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2017 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$642,579
R01 · FY2016 · HL · contact PI
Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHD$647,349
R01 · FY2015 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$127,683
K08 · FY2014 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$127,683
K08 · FY2013 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$132,493
K08 · FY2012 · HL · contact PI
BAFF Pathology: Novel Therapeutic Targets in Chronic Graft versus Host Disease$132,493
K08 · FY2011 · HL · contact PI